Page last updated: 2024-09-02

afdx 116 and pyridostigmine bromide

afdx 116 has been researched along with pyridostigmine bromide in 1 studies

Compound Research Comparison

Studies
(afdx 116)
Trials
(afdx 116)
Recent Studies (post-2010)
(afdx 116)
Studies
(pyridostigmine bromide)
Trials
(pyridostigmine bromide)
Recent Studies (post-2010) (pyridostigmine bromide)
3671241,792179404

Protein Interaction Comparison

ProteinTaxonomyafdx 116 (IC50)pyridostigmine bromide (IC50)
AcetylcholinesteraseHomo sapiens (human)0.355

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albuquerque, EX; Aracava, Y; Castro, NG; Fawcett, WP; Pereira, EF; Randall, WR; Santos, MD1

Other Studies

1 other study(ies) available for afdx 116 and pyridostigmine bromide

ArticleYear
Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:1

    Topics: Animals; Atropine; Central Nervous System; Cholinesterase Inhibitors; Cholinesterases; Electric Stimulation; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Membrane Potentials; Muscarinic Antagonists; Neurons; Patch-Clamp Techniques; Piperidines; Pirenzepine; Pyramidal Cells; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Receptors, Nicotinic; Soman; Synaptic Transmission

2003